Company intelligence / Profile preview

Luminas

Ownership: Private
Development stage: Other

Overview

LUMINAS offers drug-free, non-invasive pain and inflammation relief patches using a proprietary technology that embeds an electrical charge into a wearable patch. Clinical data cited by the company show significant reductions in pain scores and inflammation for most users. The product has been used by professional athletes and sold over 30 million units.

Therapeutic areas: ImmunologyNeurology
Modalities: Device (specifically, electroceutical patch)Non-pharmacological therapy
Industry: Consumable Medical Devices

Partnerships

Not specified publicly; some endorsements from professional athletes but no major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on Luminas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luminas.

Explore the full profile